“jeff-jonas” Archives

in
Entry Author Date Location
Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug 04/07/20 Boston
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
The Winners of the 2019 Xconomy Awards Boston Are… 09/12/19 Boston
The Finalists for the 2019 Xconomy Awards Are … 07/10/19 Boston
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges 01/07/19 Boston
Xconomy Awards 2018 Gala Honors the Best of Boston Life Science: Slideshow 10/11/18 Boston
The Art of Perseverance: Meet Xconomy’s Six CEO Award Finalists 07/02/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
Sage Speeds Ahead With Plans For a Short-Course Depression Drug 06/12/18 Boston
Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test 12/07/17 Boston
Sage Bounces Back, Eyes FDA Filing for Postpartum Drug 11/09/17 Boston
All Eyes on Depression Trials as Sage Neuro Drug Flunks Epilepsy Test 09/12/17 Boston
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
Caveats But No “Quicksand” In Sage’s Positive Postpartum Trial Data 07/12/16 Boston
With Positive Postpartum Results, Sage Ponders More Mood Disorders 07/12/16 Boston
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Sage Points to Tremor Data to Back Up “De-Risked” Neuro Drug Plan 09/03/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
Sage Preps For Final Test As Epilepsy Drug Holds Up in Small Study 05/14/15 Boston
Page 1 of 1